CNS pipeline · person
Joshua Pinto, Ph.D., MBA
President of Neumora, who joined the company as Chief Financial Officer in June 2021. His earlier career included healthcare investment banking and a role in global external research and development at Eli Lilly.
- 1 company
Courtesy Neumora Therapeutics
Current roles
- Neumora Therapeutics, Inc.President · Executive2021–present
Appears with
People sharing a company with Joshua.
- Alaa Halawa · Neumora Therapeutics, Inc.
- Amy Sullivan · Neumora Therapeutics, Inc.
- Bill Aurora · Neumora Therapeutics, Inc.
- Carol Suh · Neumora Therapeutics, Inc.
- David Piacquad · Neumora Therapeutics, Inc.
- Jason Duncan · Neumora Therapeutics, Inc.
- Kristina Burow · Neumora Therapeutics, Inc.
- Matthew K. Fust · Neumora Therapeutics, Inc.
- Maykin Ho · Neumora Therapeutics, Inc.
- Michael Milligan · Neumora Therapeutics, Inc.
- Mike Poole · Neumora Therapeutics, Inc.
- Morgan Sheng · Neumora Therapeutics, Inc.
- Nicholas Brandon · Neumora Therapeutics, Inc.
- Pablo Gersberg · Neumora Therapeutics, Inc.
- Paul L. Berns · Neumora Therapeutics, Inc.
- Richard Huganir · Neumora Therapeutics, Inc.
- Robert Nelsen · Neumora Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.